Phase I pharmacokinetic trial of asunaprevir/daclatasvir/BMS 791325 in healthy volunteers.

Trial Profile

Phase I pharmacokinetic trial of asunaprevir/daclatasvir/BMS 791325 in healthy volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 13 Apr 2014

At a glance

  • Drugs Asunaprevir/becabluvir/daclatasvir (Primary) ; Asunaprevir; Beclabuvir; Daclatasvir
  • Indications Hepatitis C
  • Focus Pharmacokinetics
  • Sponsors Bristol-Myers Squibb
  • Most Recent Events

    • 03 Apr 2014 New trial record
    • 24 Mar 2014 Results will be presented at The International Liver Congress, the 49th annual meeting of the European Association for the Study of the Liver (EASL) according to a Bristol-Myers Squibb media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top